BNGO BioNano Genomics Inc

For the fiscal year ended 31/12/2022: BioNano Genomics Inc's revenues increased by 54.62% and amounted to 27.80M. Net income decreased by 83.06% to -132.60M. Net assets decreased by 26.02% to 249.40M and EPS decreased from -0.25 to -0.46.